Производител
GSK Vaccines S.r.l
2 продукта в каталога
| Търговско име | Концентрация | Форма |
|---|---|---|
| Bexsero | --¹ One dose (0.5 ml) contains: Recombinant Neisseria meningitidis group B NHBA fusion protein ¹, ², ³ 50 micrograms Recombinant Neisseria meningitidis group B NadA protein ¹, ², ³ 50 micrograms Recombinant Neisseria meningitidis group B fHbp fusion protein ¹, ², ³ 50 micrograms Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254 measured as amount of total protein containing the PorA P1.4² 25 micrograms ¹ produced in E. coli cells by recombinant DNA technology ² adsorbed on aluminium hydroxide (0.5 mg Al³+) ³ NHBA (Neisseria Heparin Binding Antigen), NadA (Neisserial adhesin A), fHbp (factor H binding protein) | инжекционна суспензия |
| Menveo | --¹ One dose (0.5 ml) contains: Meningococcal group A oligosaccharide 10 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 16.7 to 33.3 micrograms Meningococcal group C oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 7.1 to 12.5 micrograms Meningococcal group W135 oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 3.3 to 8.3 micrograms Meningococcal group Y oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 5.6 to 10.0 micrograms | Powder and solution for solution for injection |